Figure 2 | Scientific Reports

Figure 2

From: Bleeding patients on extracorporeal membrane oxygenation have reduced platelet aggregation and plasma fibrinogen: a longitudinal observational study

Figure 2

Thromboelastometry (ROTEM®) results and thrombin–antithrombin (TAT) complex plasma levels from 100 patients on day 1 ± 1 (n = 87), 4 ± 1 (n = 74), 7 ± 1 (n = 44), and 14 ± 2 (n = 11) during extracorporeal membrane oxygenation therapy. Selected results from EXTEM, INTEM and FIBTEM assays are presented, as well as the calculated platelet maximum clot elasticity (MCE). P-values reflect comparison to a healthy control group. MAXVEL maximum velocity, MCF maximum clot firmness, MCE maximum clot elasticity, TAT thrombin–antithrombin complex.

Back to article page